PAR-1 activation by SFLLRNP decreases myelin deposition on lumbar motor neuron axons as assessed with cupric silver staining by Candice Meuleners & Victoria Turgeon
Page 1 of 9 
PAR-1 activation by SFLLRNP decreases myelin deposition on lumbar motor neuron axons as assessed with cupric silver staining 
    2010 
 
PAR-1 activation by SFLLRNP decreases myelin deposition on 
lumbar motor neuron axons as assessed with cupric silver staining 
 
Candice Meuleners
1 and Victoria Turgeon
1 
1Furman University, Greenville, South Carolina 29617 
 
Working through protease-activated receptors (PARs), serine proteases have been shown to play 
important roles in neuronal and glial cell survival during development and in neurodegeneration.  
Past studies in chick embryos have shown that PAR-1 activation during the period of lumbar 
motor neuron programmed cell death (PCD) leads to a decreased number of surviving motor 
neurons by embryonic day 10 (E10).  Retrospective analysis of these tissues revealed increased 
thionin staining in the white matter of these spinal cords, interesting because thionin does not 
normally  stain  myelinated  areas.  We  hypothesized  that  PAR-1  activation  decreases  myelin 
deposition in developing spinal cords.  To activate PAR-1, embryos were treated with the amino 
acid sequence SFLLRNP for five consecutive days beginning on E5.  Embryos were sacrificed 
on  E10,  prepared  for  histology,  and  stained  with  cupric  silver.    The  ventral  hemispheres  of 
lumbar sections were examined for the degree of demyelination as characterized by punctate or 
linear  silver  markings  in  the  white  matter.    Experimental  embryos  were  found  to  exhibit 
statistically more punctate markings and linear markings.  This study shows that in addition to 
decreasing motor neuron survival, PAR-1 activation potentially decreases the conducting ability 
and viability of the surviving motor neurons.  
 
Abbreviations:  PAR – protease-activated receptor; E – embryonic day; SFLLRNP – serine-
phenyalanine-leucine-leucine-arginine-asparagine-proline; PCD – programmed cell death; ALS 
– Amyotrophic Lateral Sclerosis 
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Introduction 
 
  Protease activated receptors (PARs), 
are  transmembrane  cell  surface  receptors 
activated  by  proteolytic  cleavage  of  the 
extracellular  domain.  Extracellular  serine 
proteases  remove  a  portion  of  the  N-
terminus.    While  the  removed  portion  is 
digested  by  circulating  macrophages,  the 
remaining  amino  acid  sequence  on  the  N-
terminus  undergoes  a  conformational 
change  allowing  it  to  bind  to  its  own 
transmembrane  segment.  This  sequence  of 
events  results  in  the  receptor’s  activation 
(Steinhoff  et  al.,  2005).    In  PAR-1,  the 
protease thrombin activates the receptor by 
exposing  the  amino  acid  sequence  serine-
phenylalanine-leucine-leucine-arginine-
asparagine-proline, or SFLLRNP (Vu et al., 
1991; reviewed in Salman et al., 2003).  By 
exposing  the  receptor  to  SFLLRNP 
(Turgeon et al., 1998; Salman et al., 2003), 
or other similar truncated peptides (such as 
SFLLRN) from the N-terminus, thrombin’s 
effect on PAR-1 is replicated (Smirnova et 
al., 2001). 
  The role of PAR-1 activation during 
coagulation  and  immune  responses  is  well 
established  (Steinhoff  et  al.,  2005),  but 
PAR-1’s role in the nervous system is less Page 2 of 9 
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understood.    Following  the  discovery  of 
PAR-1  mRNA  localization  in  motor 
neurons, dorsal root ganglia (Niclou et al., 
1998),  and  oligodendrocytes  (Wang  et  al., 
2004), to name a few, several studies have 
emerged  showing  that  PAR-1  activation 
affects  neuronal  and  glial  cells  in  various 
ways depending on the cell type, period of 
development,  and  other  factors  such  as 
trauma (reviewed in Turgeon and Houenou, 
1997).    Stunted  neurite  growth  and 
increased apoptosis in motor neurons is seen 
following  PAR-1  activation  both  in  vitro 
(Turgeon et al., 1998) and in vivo (Turgeon 
et  al.,  1999).    However,  PAR-1  activation 
can  be  neuroprotective  depending  on  the 
concentration  of  thrombin  (Donovan  and 
Cunningham,  1998),  and  the  specific 
physiological  condition  of  the  system 
(reviewed  in  Turgeon  et  al.,  2000).    For 
example, Vaughan et al., (1995) documents 
that  treatment  with  SFLLRN  elicits 
neuroprotection  for  hippocampal  neurons 
and  astrocytes  during  periods  of 
hypoglycemia  and  oxidative  stress,  while 
under  normal  circumstances  these 
concentrations  of  thrombin  are  toxic.  
Therefore,  PAR-1  and  thrombin  may  be 
involved  in  the  balance  between 
neuroprotection  and  neurodegeneration 
throughout the nervous system (Rohatgi et 
al., 2004). 
  While  neurodegeneration  is  often 
associated  with  disease,  it  is  not  always 
detrimental  to  the  organism;  in  fact,  it  is 
normal for developing organisms to undergo 
deliberate modification of neural elements, 
including  the  axon  (Luo  and  O’Leary, 
2005).  These modifications, made through 
retraction  and/or  degeneration,  are 
responsible  for  establishing  meaningful 
connections  and  are  involved  in  neural 
plasticity  (Luo  and  O’Leary,  2005).    In 
developing  systems,  neurodegeneration  is 
hypothesized  to  be  accomplished  through 
cell-intrinsic  programs,  including  receptor 
activation and axon pruning that results in 
synapse  elimination  (Luo  and  O’Leary, 
2005). Such plasticity is normally observed 
during  nervous  system  development  and 
maintenance  (reviewed  in  Oppenheim, 
1991),  but  neurodegeneration  that  occurs 
outside  of  development  could  lead  to 
diseases,  such  as  Amyotrophic  Lateral 
Sclerosis (ALS) or exacerbate damage from 
a spinal cord injury.  
  While  PAR-1  activation  has  been 
shown to decrease motor neuron survival in 
development  (Turgeon  et  al.,  1998; 
Smirnova et al., 1998; Turgeon et al., 1999) 
and decrease neurite length in vitro (Jalink 
and Moolenaar, 1992; Turgeon et al., 1998), 
we do not know how the remaining neurons 
have  been  affected.    However,  the  use  of 
previous slides from our lab provided a clue 
as to how the remaining cells of the spinal 
cord  may  be  affected  by  SFLLRNP 
treatment.  Slides that had previously been 
used to identify and quantify motor neurons 
were  being  used  to  train  new  research 
students  in  histology  when  the  authors 
noticed  increased  thionin  staining  in  the 
white  matter  of  those  embryos  that  were 
treated with SFLLRNP.  Thionin is a typical 
hydrophilic  stain  used  in  nervous  system 
histology,  but  it  does  not  have  a  high 
affinity  for  myelin,  which  is  hydrophobic.  
The presence of thionin staining in the white 
matter suggests that myelin is missing from 
the white matter of these tissues.   
To  replicate  the  conditions  under 
which  the  aforementioned  slides  were 
obtained  and  to  determine  if  PAR-1 
activation  was  responsible  for  myelin  loss 
and thus, the abnormal staining in the white 
matter, chicken embryos were treated with 
SFLLRNP  or  PBS  (vehicle  control).  
However,  instead  of  staining  with  thionin, 
cupric silver histochemistry was employed. 
Cupric  silver  was  used  since  it  has  been 
shown to depict accurately myelin loss (De 
Olmos  et  al.,  1994;  Festoff  et  al.,  2004; Page 3 of 9 
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Grant et al., 2004), as it not only binds to the 
unmyelinated  areas,  but  also  because  the 
deposition  of  the  individual  silver  grains 
allows  for  the  quantification  of  punctate 
(spots of demyelination) and linear (tracts of 
demyelination)  marking.    Axons  in  the 
white  matter  of  the  spinal  cord  should  be 
completely encased in myelin with regularly 
spaced  breaks  or  nodes  of  Ranvier.    The 
range  of  the  silver  grain  diameter  used  in 
this staining procedure is between 5-15 µm, 
which  is  much  larger  than  the  nodes  of 
Ranvier  at  1-2  µm,  so  that  any  silver 
markings  seen  represent  spaces  created  by 
missing  myelin  (Switzer,  1991).  Based  on 
our  previous  observations  that  SFLLRNP 
treatment  increased  thionin  deposition, 
presumably  due  to  decreased  myelin,  we 
expected  to  see  increased  cupric  silver 
staining in the white matter, supporting our 
hypothesis  that  PAR-1  activation  leads  to 
decreased  myelin  deposition  during 
development. 
 
 
Material and Methods 
 
  Fertilized  Gallus  gallus  eggs  were 
obtained  from  Charles  E.  Morgan  Poultry 
Center  (Clemson,  SC).    On  E3,  the  eggs 
were windowed to reveal the chorioallantoic 
membrane containing the external vascular 
supply connecting the embryo to the extra-
embryonic yolk and surrounding fluids.  The 
resultant  holes  in  the  shells  were  resealed 
with transparent tape before returning them 
to the incubator (Percival Scientific; Atlanta, 
GA;  37°C,  95%  relative  humidity).  
Experimental embryos (n=20) were treated 
daily (E5-E9) by pipetting 200µL of 100µM 
SFLLRNP  (Anaspec,  San  Jose,  CA)  onto 
the chorioallantoic membrane, whereby the 
solution  was  absorbed  and  delivered 
throughout  the  embryo.    Control  embryos 
(n=20) were treated in a similar manner with 
200µL  of  1X  phosphate  buffered  saline 
(PBS;  Sigma,  St.  Louis,  MO).    Before 
treating  the  embryos,  the  allotted  volumes 
were  incubated  at  37°C  for  a  period  no 
longer than 5 minutes to minimize the shock 
to the embryos.  On E10 the embryos were 
sacrificed by decapitation and fixed in 4% 
paraformaldehyde  (Fisher  Scientific, 
Atlanta,  GA)  overnight  and  transferred  to 
70%  ethanol  for  another  overnight  period.  
Embryos  were  then  post-fixed  in  a  30% 
sucrose  solution  (Fisher)  made  up  in  4% 
paraformaldehyde and were kept in the post-
fixative  until  they  sank  below  the  surface.  
Cryostat  (2800  Frigocut  N,  Reichert  Jung; 
Depew, NY) sections were cut at 25µm (-
27°C) and every tenth section was mounted 
on  gel-coated  slides  (Lab  Scientific  Inc., 
Livingston, NJ).  
 
Cupric Silver Staining 
  Cupric  silver  staining  was  carried 
out using the protocol by De Olmos et al. 
(1994).    As  directed,  all  glassware  was 
washed with neutralized nitric acid (Fisher).  
The  pre-impregnation  solution  [198.71  mg 
AgNO3 (Sigma, St. Louis, MO), 198.71 mL 
dH2O,  1.20  mL  n-butyric  acid  (Fisher), 
91.40  mg  dl-α-alanine  (Sigma),  0.5% 
Cu(NO3)2  (Fisher),  0.5%  Cd(NO3)2  (Alfa 
Aesar,  Ward  Hill,  MA),  0.5%  La(NO3)3 
(Sigma), 0.5% Neutral Red (Fisher), 1.987 
mL  pyridine  (JT  Baker,  Phillipsburg,  NJ), 
1.987 mL triethanolamine (Sigma), 3.97 mL 
isopropanol  (Carolina  Biological  Supply, 
Burlington,  NC)]  was  microwaved  at  60% 
power to reach 50°C and cooled for 1 hour.  
Slides  were  dipped  in  dH2O  and  then 
transferred to the pre-impregnation solution 
at  50°C  for  45-50  minutes.    After  this 
period,  slides  were  cooled  to  room 
temperature.  The diamine solution [6.975 g 
AgNO3 (Sigma), 84.6456 mL dH2O, 67.717 
mL  100%  ethanol,  0.846  mL  acetone 
(Fisher),  0.4%  LiOH  (Sigma),  11.004  mL 
NH4OH (Sigma)] was made up during this 
cooling  period.    Slides  went  through  two Page 4 of 9 
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washes of acetone for 30-60 seconds before 
being moved into the diamine solution for 
45-50  minutes  under  constant  agitation 
(Orbitron Rotator II 260250; Fisher).  The 
reducer solution [10% formalin (Sigma), 1% 
citric  acid  anhydrous  (Sigma),  21.32  mL 
100% ethanol, 189.53 mL dH2O) was made 
up during this time.  Slides were then moved 
to  the  reducer  solution  for  25  minutes  at 
32°C.  While in the reducer solution for the 
25  minutes  several  additional  steps  were 
taken.    The  protocol  required  that  the 
reducer solution be constantly stirred for the 
first  2  minutes.    After  an  additional  3 
minutes in the reducer solution, 0.65 mL of 
the diamine solution was added and again at 
5 minute intervals until the 20 minute mark.  
Slides  were  placed  in  0.5%  glacial  acetic 
acid  (Fisher)  for  1-2  minutes,  and  then 
moved to dH2O for 15 minutes.  The slides 
were left overnight in another dH2O wash.  
Bleaching  solutions  were  made  up  before 
starting the second part of the stain.  Slides 
were washed in the first bleaching solution 
[6% potassium ferricyanide (Sigma) in 4% 
potassium chloride (Acros Organics, Morris 
Plains, NJ), 4.216 mL undiluted lactic acid 
(Fisher)]  for  20-60  seconds,  being  careful 
not  to  completely  remove  the  color.    The 
slides were moved to a 2 minute dH2O wash 
before exposing them for 15-20 seconds to 
the  second  bleaching  solution  [0.06% 
potassium  permanganate  (JT  Baker),  5% 
sulfuric  acid  (Fisher)].    The  slides  were 
placed in dH20 and remained there while 2% 
sodium  thiosulfate  (Sigma)  and  Kodak 
Rapid  Fixer  (Eastman  Kodak  Company, 
Rochester, NY) were made up.  Slides were 
put in 2% sodium thiosulfate (Fisher) for 1-
3  minutes  under  constant  agitation,  then 
moved  to  dH2O  for  2-5  minutes  before 
being  put  in  Rapid  Fixer  for  1-5  minutes.  
Slides  were  placed  in  dH2O  before  being 
serially dehydrated (70%-95%-100% EtOH) 
ending  in  SafeClear  (Fisher).    Slides  were 
then coverslipped.   
 
Microscopy  
  Slides  were  observed  at  400X  total 
magnification  using  a  light  microscope 
(Meiji; Martin Microscope, Easley, SC) and 
photographed  with  a  Nikon  Coolpix  990 
camera.    The  photographs  were  imported 
and analyzed with PhotoImpression, version 
5.1.8.83 (ArcSoft Inc., Freemont, CA).  All 
of the white matter from the lowest point of 
the central canal encompassing both ventral 
horns of the spinal cord was examined for 
the number of punctate and linear markings 
(n=25  cross  sections  per  embryo)  (Fig  1).    
The average number of punctate and linear 
markings were then determined per embryo. 
 
 
 
Figure 1. Characterization of demyelination as shown 
by cupric silver staining of lumbar spinal cord sections 
in Gallus gallus embryos following PAR-1 activation 
by  treatment  with  SFLLRNP.    Isolated  circular 
markings were classified as punctate and markings of 
extended  length  were  classified  as  linear.  The  white 
matter  of  the  spinal  cord  pictured  here  displays  two 
distinct  markings:  punctate  and  linear.    Punctate 
markings are surrounded by circles and linear markings 
surrounded by ovals.  
30 µm Page 5 of 9 
PAR-1 activation by SFLLRNP decreases myelin deposition on lumbar motor neuron axons as assessed with cupric silver staining 
    2010 
 
Statistical Analysis 
Statistical  analyses  were  computed 
using JMP IN, version 5.1.2 (SAS Institute, 
2001).  After the data was determined to be 
normally distributed (Goodness of Fit test), 
a  Student’s  t-test  (α=0.05)  was  used  to 
analyze  the  differences  in  the  number  of 
punctuate  markings  between  control  and 
SFLLRNP-treated  sections  and  then  in 
linear markings between the two groups. 
 
Results 
 
  Using a Goodness of Fit test all data 
was  found  to  be  normally  distributed. 
Increased  deposition  of  cupric  silver  was 
observed  in  the  embryos  treated  with 
SFLLRNP  (Fig.  2A-D).  Experimental 
embryos were found to have a significantly 
higher  number  (mean  +  SEM)  of  linear 
markings  (264.5  +  67.90;  Student’s  t-test: 
df=6;  p=0.0280)  as  well  as  a  significantly 
higher number of punctate markings (180.25 
+ 44.53; Student’s t-test: df=6; p=0.0312) in 
comparison  to  the  control  embryos  (4.3  + 
2.3 punctate and 2.3 + 1.45 linear; Fig. 3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Representative spinal cord cross-sections taken from the lumbar regions of control and experimental chick 
embryos.  From E5-E9 embryos were treated with PBS (control) or SFLLRNP and stained with cupric silver to assess 
axon degeneration.  Panels A and C show an overview of sample sections (40X total magnification slight variation in 
cord level) while panels B and D (400X total magnification) show the white matter around the ventral motor horn.  
Panels A and B represent controls with little to no staining and C and D represent the experimental with markedly 
increased staining.   
Figure 3. Mean silver markings (± SE) observed in the 
ventral  half  of  spinal  cord  white  matter  following 
treatment  with  PBS  (control)  or  100µM  SFLLRNP.  
Punctate (A) and linear markings (B) were significantly 
higher  in  SFLLRNP-treated  embryos  (p=0.0312  and 
0.0280, respectively; df=6 for both groups).  
PBS-treated        SFLLRNP- treated                  Page 6 of 9 
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Discussion 
 
Since  the  diameter  of  the  silver 
grains  make  them  too  large  to  adhere  to 
nodes of Ranvier, the silver grains observed 
in the slides represent unmyelinated areas in 
the  spinal  cord.  Therefore,  the  fact  that 
embryos  treated  with  SFLLRNP  had 
significantly  more  silver  markings  suggest 
that PAR-1 activation by SFLLRNP during 
the  naturally  occurring  PCD  for  this 
population  of  neurons  (E5-E10)  decreases 
the deposition of myelin along the axons of 
Gallus gallus embryos.  It can be concluded 
that  markings  observed  are  not  due  to 
normal  developmental  pruning  because  a 
significant loss of myelin occurred only in 
the  SFLLRNP-treated  embryos  (Fig  3).  
Instead,  the  degeneration  observed  is 
pathological.    
The  punctate  and  linear  markings 
quantified in this study could be the result of  
PAR-1  activation  on  the  oligodendrocytes, 
since these cells do possess PAR-1 (Wang et 
al., 2004). This activation could result in a 
loss of oligodendrocytes, thereby decreasing 
the number of myelinating cells in the CNS, 
or  it  could  result  in  decreased  myelin 
production  through  process  retraction.  
Although  the  length  of  the  avian 
oligodendrocyte  sheath  contacting  an  axon 
can  be  quite  variable  (Anderson,  2003)  at 
E10,  the  punctate  markings  depicted  by 
single  silver  grains  (5-15  µm)  were 
interpreted  to  represent  places  where  a 
single  myelinating  process  from  an 
oligodendrocyte  was  lost.  Linear  markings 
were  interpreted  to  represent  places  where 
multiple processes were affected.   
Whether  specific  markings  were 
generated  by  the  retraction  of  several 
oligodendrocyte  processes  from  one  cell, 
from multiple cells, or were the result of cell 
death is not yet known.  However, studies 
examining  oligodendrocyte  numbers  and 
myelin  production  following  PAR-1 
activation  are  currently  underway  in  the 
laboratory.    These  studies  will  examine 
whether  PAR-1  activation  on  the 
oligodendrocytes is the underlying cause of 
the decreased myelin deposition.   
It is also possible that the decreased 
myelin  is  the  result  of  an  inflammatory 
response  as  PAR-1  activation  has  been 
shown to be involved in the cellular process 
of inflammation (Steinhoff et al., 2005).  In 
a study regarding spinal cord injury, Festoff 
et  al.,  (2004)  supports  thrombin’s 
proinflammatory  actions  in  producing 
secondary cell injury.  Secondary cell injury 
occurs  after  the  original  disturbance  and 
results  from  the  damage  of  surrounding 
vasculature  as  well  as  the  initiation  of 
inflammatory  responses  (Mautes  et  al., 
2000).    Inflammatory  cells  are  able  to 
infiltrate the area after a breach in the blood-
spinal cord barrier (Schlosshauer, 1993) and 
their presence has been shown to correlate 
with  belated  neuronal  death  and 
demyelination  (reviewed  in  Mautes  et  al., 
2000).   
  Similarly,  when  the  blood-brain  or 
blood-nerve  barrier  is  compromised, 
fibrinogen  is  able  to  enter  neural  tissue 
where it can activate intercellular signaling 
pathways,  causing  extracellular  matrix 
rearrangement (Akassoglou and Strickland, 
2002).  Under this disruption of the blood-
brain  barrier  active  thrombin  can  be 
generated  (reviewed  in  Turgeon  and 
Houenou,  1997).    Thrombin  can  then 
convert this fibrinogen into fibrin (Xi et al., 
2003)  and  subsequently  cause  damage  to 
neural cells or changes in the myelin sheath.  
Kwon  and  Prineas  (1994)  showed  that 
inflammatory  demyelination  can  be  linked 
to fibrinogen accumulations in the plaques 
formed in multiple sclerosis. Although it is 
possible  that  the  vasculature  was 
compromised  by  SFLLRNP  treatment 
leading  to  a  secondary  inflammatory 
response  or  changes  in  the  extracellular Page 7 of 9 
PAR-1 activation by SFLLRNP decreases myelin deposition on lumbar motor neuron axons as assessed with cupric silver staining 
    2010 
 
matrix, no apparent vascular changes were 
observed.    To  examine  this  possibility 
further,  transmission  electron  microscopy 
techniques  would  need  to  be  employed  to 
more closely examine the ependymal lining 
of the blood-spinal cord barrier.   
    It  is  clear  that  from  this  study  and 
others that PAR-1 has a deleterious effect on 
developing  motor  neurons,  but  it  is  not 
known  whether  this  is  a  direct  or  indirect 
effect.  Astrocytes  (Donovan  et  al.,  1997) 
and motor neurons (Smirnova et al., 1998; 
Turgeon et al., 1998) are induced to undergo 
caspase-mediated  apoptosis  immediately 
following  PAR-1  activation  implying  a 
direct  effect.    However,  in  other  events 
related to PAR-1 activation, such as neurite 
rounding (Jalink and Moolenaar, 1992) and 
retraction  (Jalink  and  Moolenaar,  1992; 
Turgeon et al., 1998), it is unclear as to how 
these  events  are  stimulated.    It  is  highly 
possible that PAR-1 activation affects motor 
neuron  cell  survival  through  both  a  direct 
and indirect pathway.  Initial activation of 
the PAR-1 receptor on motor neurons could 
lead to cell death through caspase activation 
(Turgeon et al., 1998), but subsequent motor 
neuron  cell  death  could  ensue  following 
demyelination  of  the  surviving  motor 
neuron  axons.  Circulating  serine  proteases 
are  present  during  PCD,  but  up  until  now 
the  focus  has  been  solely  on  their  direct 
impact on the neurons.  The fact that many 
motor neurons survive PCD suggests that at 
some point in development either PAR-1 or 
the  serine  proteases  are  down-regulated.; 
whereas,  abnormal  down-regulation  could 
result in fewer surviving motor neurons.  
Regardless  of  the  specific 
components  and  steps  involved  in  myelin 
formation,  myelin  plays  a  direct  role  in 
signal  transduction  and  an  indirect  role  in 
neuronal  survival.    Action  potentials  are 
propagated  down  the  length  of  the  axon 
through  the  opening  of  voltage-gated  Na+ 
channels.    Myelin  effectively  reduces  the 
time it takes for an action potential to reach 
the  distal  end  of  the  axon  by  increasing 
capacitance along the length of the axon and 
reducing the number of Na+ channels that 
must be activated. Therefore any decrease in 
the  myelin  components  may  impair 
conduction  signals  of  the  affected  motor 
neurons.  Decreased transmission from the 
neuron  to  the  target,  not  only  slows 
stimulation of the target cell, but may also 
have indirect effects on continued viability 
of  the  neuron.    In  the  case  of  the  motor 
neuron,  its  target  is  a  muscle  cell,  which 
upon  stimulation  contracts,  and  also 
produces  growth/neurotrophic  factors  that 
are  retrogradely  transported  from  the  axon 
terminal  to  the  cell  body  (Deshmukh  and 
Johnson  1997).    The  neurotrophic 
hypothesis  contends  that  access  to  target-
derived  growth  factors  is  essential  to 
neuronal  survival  and  that  any  condition 
limiting their access or uptake would affect 
neuronal  cell  viability  (Oppenheim  et  al., 
1988).  Clarifying the mechanisms involved 
in cell survival following PAR-1 activation 
is important to not only understanding these 
processes  that  regulate  spinal  cord 
development,  but  also  for  those  processes 
that  mitigate  cell  death  when  PAR-1  is 
improperly activated as has been suggested 
in  spinal  cord  injuries  and  in  certain 
neurodegenerative  diseases  such  as  ALS.  
While further research is needed in this area, 
we  have  provided  evidence  that  PAR-1 
activation  has  both  short-  and  long-term 
affects in spinal cord.         
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